This site is intended for healthcare professionals only
LoginRegister

Marksans Pharma Goa facility gets Australian nod to manufacture pharma formulations for Australian markets

Ruchika SharmaWritten by Ruchika Sharma   |  
Marksans Pharma Goa facility gets Australian nod to manufacture pharma formulations for Australian markets
  • whatsapp
  • Telegram

Mumbai: Marksans Pharma Limited has announced that its manufacturing facility located at Plot A-1, Phase 1-A, Verna Industrial Estate, Verna, Goa has been approved by Australian TGA for manufacture of pharmaceutical formulations in Solid Dosage Forms of Tablets and hard Capsules for Australian markets.

The products will be manufactured at the above facility in Goa India and marketed & distributed in Australian markets through the Company’s subsidiary Nova Pharmaceuticals Australasia Pty Ltd.

In August 2024, the US Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for the manufacturing facility of the Company located at Plot No. L-82 & L-83, Verna Industrial estate, Verna, Goa.

Read also: USFDA issues EIR for Marksans Pharma Goa facility

Marksans Pharma Limited headquartered at Mumbai, India is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets. The company's manufacturing facilities located in India, USA and UK are approved by several leading regulatory agencies including USFDA, UKMHRA and Australian TGA. The company's product portfolio spreads over major therapeutic segments of CVS, CNS, Anti-diabetic, Pain Management, Gastroenterological and Antiallergies. The company is marketing these products globally.

Read also: Marksans Pharma arm gets marketing authorization for muscle relaxant tablets in UK

marksans pharmamarksans pharma newsNova Pharma
Ruchika Sharma
Ruchika Sharma

    Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story
    X